Project Grant R21AG087921
Award Date
9/1/24
Completion Date
6/30/26
Dollars Obligated
$445K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $4,276,054 to The Regents of the University of California, San Francisco (UCSF) to develop mathematical models and analytical tools that can quantitatively test hypotheses about the selective vulnerability of specific brain regions, cell types, and neural networks in mouse models of Alzheimer's disease (AD) tauopathy. The project aims to leverage two enabling technologies recently...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $109,595 to the University of California, Davis (UC Davis) to conduct microscopic studies and behavioral analysis on a novel Alzheimer's disease monkey model. Specifically, the project aims to: Comprehensively characterize the regional and laminar patterns of tau-based neuropathology and neuronal loss within the entorhinal cortex, hippocampus, and neocortical regions of the monkey brain at 12...
This $519,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a 2-year research study by the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco. The study aims to explore the underlying molecular mechanisms by which reducing levels of the tau protein can prevent or diminish excitation/inhibition imbalance and network hyperexcitability in the brain. This imbalance has been observed in various...
This three-year, $5.782 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will support research into single-cell characterization of frontotemporal lobar degeneration caused by mutations in the progranulin gene. The University of California, San Francisco will map the transcriptome and gene regulatory networks that define glial pathology and neuronal vulnerability in the frontal cortex and thalamus of progranulin-deficient...
The National Institute on Aging (NIA) awarded a $791,086 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the Northern California Institute for Research and Education, Inc. (NCIRE) to develop computational models that can predict the presence of non-Alzheimer's disease neuropathological changes (non-ADNC), such as Lewy body disease, TDP-43 proteinopathy, and cerebral amyloid angiopathy, in individuals with Alzheimer's disease neuropathological changes. The project...
This $408,638 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the effect of trans-synaptic spread of pathogenic tau protein from the entorhinal cortex to the hippocampus in Alzheimer's disease (AD) and other neurodegenerative conditions. The 2-year project at Virginia Commonwealth University will use adeno-associated viral vectors, immunofluorescence, and cellular electrophysiology to monitor tau spread and assess its...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,332,368.00 to The Regents of the University of California, San Francisco (UCSF) to conduct a longitudinal, multimodal imaging study investigating the role of neuronal dysfunction and hyperexcitability in the early biological progression of Alzheimer's disease. The key objectives are to: 1) Identify the earliest manifestations of neural circuit hyperexcitability that predict the...
This $767,112 federal Project Grant award was provided by the Department of Health and Human Services' National Institute on Aging under the Aging Research program (CFDA 93.866). The University of California, San Diego (UCSD) will use the funding to investigate the contribution of genetic risk factors and microglial BIN1 expression to the development of tauopathy, a hallmark of Alzheimer's disease. The project aims to identify the downstream pathways and mediators of microglial BIN1, examine the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $119,071 to The Regents of the University of California, San Francisco (UCSF) to develop innovative computational tools to recreate and validate frontotemporal dementia (FTD) tau amyloid epitopes, with the ultimate goal of using these soluble epitopes to produce monoclonal antibodies and perform high-throughput small molecule drug screening for FTD therapeutics. The research aims to elucidate...